06/26/2025
7:54 AM | Syndax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2025
11:34 AM | GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
Syndax Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
05/07/2025
10:25 AM | MORGAN STANLEY (Filed by)
Syndax Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
03/17/2025
5:01 AM | Metzger Michael A (Reporting)
Syndax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
10:13 AM | Syndax Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SCHEDULE 13G/A | |
03/06/2025
3:10 PM | Metzger Michael A (Reporting)
Syndax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
8:18 AM | Syndax Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/03/2025
6:02 AM | Syndax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/03/2025
6:05 AM | Syndax Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2025
4:18 PM | Kynam Capital Management, LP (Filed by)
Syndax Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/12/2025
4:13 PM | Gallagher Neil (Reporting)
Syndax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for SNDX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Syndax Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
02/12/2025
4:15 PM | Metzger Michael A (Reporting)
Syndax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
4:16 PM | Goldan Keith A. (Reporting)
Syndax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
10:39 AM | GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
Syndax Pharmaceuticals (Subject)
| Form SCHEDULE 13G | |
02/10/2025
2:17 PM | Gallagher Neil (Reporting)
Syndax Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/10/2025
2:20 PM | Metzger Michael A (Reporting)
Syndax Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/10/2025
2:29 PM | Goldan Keith A. (Reporting)
Syndax Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/07/2025
3:35 PM | Jarrett Jennifer (Reporting)
Syndax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2025
3:37 PM | Katkin Keith (Reporting)
Syndax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2025
3:38 PM | Meury William (Reporting)
Syndax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2025
3:39 PM | Rizo Aleksandra (Reporting)
Syndax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2025
3:41 PM | Podlesak Dennis (Reporting)
Syndax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2025
3:42 PM | Metzger Michael A (Reporting)
Syndax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2025
3:44 PM | Goldan Keith A. (Reporting)
Syndax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2025
3:45 PM | Gallagher Neil (Reporting)
Syndax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2025
3:32 PM | Legault Pierre (Reporting)
Syndax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
9:03 AM | MORGAN STANLEY (Filed by)
Syndax Pharmaceuticals (Subject)
| Form SCHEDULE 13G | |
01/22/2025
4:50 PM | Point72 Asset Management, L.P. (Filed by)
Syndax Pharmaceuticals (Subject)
| Form SCHEDULE 13G | |
12/20/2024
4:00 PM | Syndax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2024
6:05 AM | Syndax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
9:52 AM | Syndax Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
11/05/2024
3:02 PM | Syndax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/05/2024
3:03 PM | Syndax Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/18/2024
10:49 AM | STATE STREET CORP (Filed by)
Syndax Pharmaceuticals (Subject)
| Form SC 13G/A | |
Free SNDX Stock Alerts